Latest Clinical Trials
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics Murdoch Childrens Research Institute NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE3 Goal-Directed Sedation in Mechanically Ventilated Infants and Children Vanderbilt University Medical Center NA
ACTIVE NOT RECRUITING
(Sep 1, 2026)
PHASE3 Intraoperative Midazolam on Delirium Outcome of Elderly Patients Chinese PLA General Hospital NA
COMPLETED
(Sep 1, 2026)
PHASE1 Comparing Two Doses of Midazolam With Added Dexmedetomidine for Kids Before Surgery Cairo University NA
COMPLETED
(Sep 1, 2026)
PHASE2 An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis Hoffmann-La Roche NA
RECRUITING
(Sep 1, 2026)
PHASE1 A Study of LY4355756 in Healthy Participants Eli Lilly and Company NA
RECRUITING
(Sep 1, 2026)
PHASE1 A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer Aragon Pharmaceuticals, Inc. NA
ACTIVE NOT RECRUITING
(Aug 1, 2026)
PHASE1 Understanding How Ketamine Brings About Rapid Improvement in OCD Stanford University NA
COMPLETED
(Aug 1, 2026)
PHASE2 Enhancing Week-long Psychological Treatment for PTSD With Ketamine Yale University NA
ACTIVE NOT RECRUITING
(Aug 1, 2026)
PHASE2 A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women Boehringer Ingelheim NA
SUSPENDED
(Aug 1, 2026)
PHASE1 A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder Janssen Research & Development, LLC NA
RECRUITING
(Aug 1, 2026)
PHASE3 Dexmedetomidine for Invasive Ventilation In the NEOnate Centre Hospitalier Intercommunal Creteil NA
NOT YET RECRUITING
(Aug 1, 2026)
PHASE2, PHASE3 A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma Pfizer NA
RECRUITING
(Aug 1, 2026)
PHASE1 A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight Novo Nordisk A/S NA
RECRUITING
(Aug 1, 2026)
PHASE1 Ketamine-enhanced Prolonged Exposure Therapy in PTSD VA Office of Research and Development NA
COMPLETED
(Jul 1, 2026)
PHASE2 Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia University Hospital, Montpellier NA
RECRUITING
(Jul 1, 2026)
PHASE3 Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone Sparrow Pharmaceuticals NA
COMPLETED
(Jul 1, 2026)
PHASE1 A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants ViiV Healthcare NA
RECRUITING
(Jul 1, 2026)
PHASE1 Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years GlaxoSmithKline NA
RECRUITING
(Jul 1, 2026)
PHASE1 A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio The Third Xiangya Hospital of Central South University NA
NOT YET RECRUITING
(Jul 1, 2026)
PHASE1 Impact of Analgesia on Success of External Version: Comparison of Spinal Anesthesia Versus Sedation Centre Hospitalier Universitaire, Amiens NA
COMPLETED
(Jun 1, 2026)
PHASE3 A Study of LY3502970 in Healthy Participants Eli Lilly and Company NA
COMPLETED
(Jun 1, 2026)
PHASE1 (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors Cogent Biosciences, Inc. NA
RECRUITING
(Jun 1, 2026)
PHASE3 A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People Boehringer Ingelheim NA
TERMINATED
(Jun 1, 2026)
PHASE1 An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer Jiangsu Hansoh Pharmaceutical Co., Ltd. NA
NOT YET RECRUITING
(Jun 1, 2026)
PHASE1 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements Turning Point Therapeutics, Inc. NA
RECRUITING
(May 1, 2026)
PHASE1, PHASE2 Ketamine for Multiple Sclerosis Fatigue Johns Hopkins University NA
ACTIVE NOT RECRUITING
(May 1, 2026)
PHASE2 A Phase 1, First-in-human Study of VX-433 Vertex Pharmaceuticals Incorporated NA
RECRUITING
(May 1, 2026)
PHASE1 KetAmine and Recovery After Mechanical VentilAtion ( KARMA ) Assistance Publique - Hôpitaux de Paris NA
NOT YET RECRUITING
(May 1, 2026)
PHASE3 Sedation vs No Sedation in Mechanically Ventilated COPD Patients Al-Azhar University NA
COMPLETED
(May 1, 2026)
PHASE2 Ketamine for Combined Depression and Alcohol Use Disorder University Hospital of North Norway NA
RECRUITING
(Apr 1, 2026)
PHASE1, PHASE2 An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates Sanofi NA
COMPLETED
(Apr 1, 2026)
PHASE1 A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants Eli Lilly and Company NA
COMPLETED
(Apr 1, 2026)
PHASE1 Nebulized Ketamine for the Treatment of Major Depressive Disorder Theresa Jacob, PhD, MPH NA
RECRUITING
(Apr 1, 2026)
PHASE3 The Effects of Remimazolam on Cerebral Blood Flow Following General Anesthesia Induction Jun Zhang NA
COMPLETED
(Apr 1, 2026)
PHASE3 The Effect of Dormicum-Ketamine Versus Dexmedetomidine on Emergence Delirium During Deep Sedation in Paediatric Burn Patients Ain Shams University NA
RECRUITING
(Apr 1, 2026)
PHASE2 Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care University Hospital, Tours NA
NOT YET RECRUITING
(Apr 1, 2026)
PHASE3 A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants UCB BIOSCIENCES, Inc. NA
COMPLETED
(Mar 1, 2026)
PHASE1 A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation. PMV Pharmaceuticals, Inc NA
RECRUITING
(Mar 1, 2026)
PHASE1 
